Srdjan R. Stankovic is President at ACADIA PHARMACEUTICALS INC (ACAD). They have made 18 open-market trades across 1 company since 2019, most recently 2022-11-21.
CIK 0001432545
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 18 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACAD | 63,081 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2022-11-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACAD | SELL | 2022-11-21 | 2022-11-22 | $15.07 | $28K | +1.7% | +5.5% | +24.2% |
| ACAD | SELL | 2022-10-15 | 2022-10-18 | $15.81 | $21K | +3.1% | -4.3% | +15.3% |
| ACAD | SELL | 2022-05-02 | 2022-05-03 | $18.18 | $104K | -15.5% | -18.7% | -29.3% |
| ACAD | SELL | 2022-02-23 | 2022-02-25 | $23.80 | $36K | +1.3% | -3.2% | -36.3% |
| ACAD | SELL | 2022-01-06 | 2022-01-10 | $23.05 | $45K | -6.5% | +18.5% | +4.3% |
| ACAD | SELL | 2021-11-22 | 2021-11-23 | $19.01 | $107K | +0.4% | +25.8% | +35.4% |
| ACAD | SELL | 2021-10-18 | 2021-10-19 | $17.41 | $23K | +1.6% | +7.3% | +18.6% |
| ACAD | SELL | 2021-04-30 | 2021-04-30 | $20.33 | $172K | +6.3% | +8.8% | +8.5% |
| ACAD | SELL | 2021-02-04 | 2021-02-08 | $50.61 | $853K | +1.3% | -47.3% | -58.8% |
| ACAD | SELL · 10b5-1 | 2021-01-12 | 2021-01-14 | $55.01 | $39K | -10.6% | -9.7% | -60.9% |
| ACAD | SELL | 2021-01-06 | 2021-01-08 | $55.12 | $10.3M | -2.2% | -3.6% | -61.1% |
| ACAD | SELL | 2020-11-20 | 2020-11-20 | $53.50 | $146K | -1.6% | +4.7% | -6.8% |
| ACAD | SELL | 2020-10-16 | 2020-10-19 | $42.56 | $110K | +14.1% | +29.7% | +28.6% |
| ACAD | SELL | 2020-06-18 | 2020-06-19 | $50.03 | $8.2M | -2.9% | +7.0% | -21.3% |
| ACAD | SELL | 2020-04-30 | 2020-05-01 | $49.21 | $424K | +3.4% | +9.8% | -4.6% |
| ACAD | SELL | 2020-04-23 | 2020-04-24 | $50.07 | $1.9M | -7.2% | -1.4% | -15.7% |
| ACAD | SELL | 2020-04-20 | 2020-04-22 | $50.08 | $10.4M | -6.2% | +3.2% | -10.0% |
| ACAD | SELL | 2019-11-19 | 2019-11-21 | $46.41 | $200K | -7.3% | -6.7% | -4.1% |
| ACAD | SELL | 2019-10-15 | 2019-10-17 | $39.65 | $41K | +6.3% | +13.4% | +14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.